Edition:
United States

People: Elekta AB (publ) (EKTAb.ST)

EKTAb.ST on Stockholm Stock Exchange

83.90SEK
24 Mar 2017
Change (% chg)

-1.15kr (-1.35%)
Prev Close
85.05kr
Open
85.05kr
Day's High
85.05kr
Day's Low
83.65kr
Volume
1,326,965
Avg. Vol
1,202,328
52-wk High
89.70kr
52-wk Low
55.80kr

Puusepp, Tomas 

Mr. Tomas Puusepp has served as Executive Director at Elekta AB (publ) since June 9, 2016. He no longer serves as President, Chief Executive Officer, and Member of the Executive Management at the Company effective as of June 10, 2016. He has held this position since May 13, 2015. He was also Executive Member of the Board of Directors of the Company since May 1, 2014. He had been Member of the Board since September 3, 2013. He also previously served as President, Chief Executive Officer and Member of the Executive Management of the Company from May 1, 2005 until May 1, 2014. Previously, he was also Acting Executive Vice President (EVP) of Europe, Africa, Latin America and Middle East at the Company from June 5, 2012 until September 1, 2012. He joined the Company in 1988. He has held various positions within the Company, including Head of Elekta's neurosurgery operations, President of Elekta's subsidiary in North America and Global Head of Elekta's sales, marketing and service operations. He has 30 years of experience in international medical technology. He held various positions at the Research Institute for Atomic Physics, Scanditronix and Ericsson before joining the Company. He is Chairman of the Board of Global Medical Investments GMI AB and Member of the Boards of The Swedish American Chamber of Commerce in New York and Permobil AB. Mr. Puusepp is Electrical Engineer and has studied Physics at Kungliga Tekniska Hogskolan i Stockholm (KTH) and Stockholms Universitet and completed Management Training (IEP) at IMD in Lausanne, Switzerland.

Basic Compensation

Total Annual Compensation, SEK 9,252,000
Restricted Stock Awards, SEK --
Long-Term Incentive Plans, SEK --
All Other, SEK --
Fiscal Year Total, SEK 9,252,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --